Scale Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Scale Management’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	$31M	Hold	1,710,451	–	–	68.19%	1
2016 Q2	$28.2M	Hold	1,710,451	–	–	66.69%	1
2016 Q1	$28.3M	Hold	1,710,451	–	–	56.51%	1
2015 Q4	$37.1M	Hold	1,710,451	–	–	56.74%	1
2015 Q3	$33.9M	Hold	1,710,451	–	–	42.13%	1
2015 Q2	$59.4M	Hold	1,710,451	–	–	38.7%	1
2015 Q1	$44.4M	Sell	1,710,451 -494,112	-22%	-$9.06M	22.19%	2
2014 Q4	$28.4M	Buy	+2,204,563	New	+$27.6M	16.23%	2

Other funds holding HZNP

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

KCM

Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Scale Management's HZNP Position: Q3 2016 in Review

Scale Management held its Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) position steady in Q3 2016 at 1,710,451 shares worth $31M. The position accounts for 68.19% of the portfolio, ranked #1.

Scale Management first reported a position in HZNP in Q4 2014 and has held it in 8 quarters since. The position peaked at $59.4M in Q2 2015. 233 funds tracked by Wall St. Rank hold HZNP as of Q3 2016.

Scale Management held 1,710,451 shares of Horizon Therapeutics Public Limited Company Ordinary Shares worth $31M as of Q3 2016.
Scale Management left its Horizon Therapeutics Public Limited Company Ordinary Shares share count unchanged in Q3 2016.
Horizon Therapeutics Public Limited Company Ordinary Shares made up 68.19% of Scale Management's portfolio in Q3 2016, its #1 holding.
Scale Management first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2014 and has held it in 8 quarters since.
Scale Management's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $59.4M in Q2 2015.
233 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q3 2016.

Based on Scale Management's 13F filing for Q3 2016, filed 14 Nov 2016.